France A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s new Chinese acquisition catapults it into the world’s top 5 CDMOs, Ipsen’s resilient performance in the first half of 2020 despite COVID-19 headwinds, and the French government’s push for more domestic pharma manufacturing.…
France Eric Goupil, CEO of Unither Pharmaceuticals, discusses the company’s development strategy moving forward after the completion of a leveraged buyout in 2017. Additionally, Goupil shares the CDMO’s innovation capabilities as a leading player in the Blow-fill-seal (BFS) niche. While the continuation of outsourcing by pharmaceutical companies is a trend,…
Pharma Eric Goupil reveals how the global CMO market has expanded considerably over recent years, with a move towards a more strategic mind-set in the pharmaceutical industry. Unither´s business model is to focus on unit-dose products and in particular, sterile unit-dose using Blow-Fill-Seal (BFS) technology and today they are competing on…
See our Cookie Privacy Policy Here